- Issuer ticker
-
ANIX
- Reported as of
-
05 Jan 2026
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
06 Jan 2026, 19:40:10 UTC
Filing notes and source
Key filing fact
Arnold M. Baskies filed Form 4 for Anixa Biosciences Inc (ANIX) on 06 Jan 2026.
Key facts
- This page summarizes Arnold M. Baskies's Form 4 filing for Anixa Biosciences Inc (ANIX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 06 Jan 2026, 19:40.
Change
- Previous filing in this sequence was filed on 21 Jul 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001683567
Primary reporting owner
Baskies Arnold M
- Relationship
-
Director
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ANIX
transaction
Derivative
Employee Stock Option
Award
- Transaction value
- $0
- Shares
- +25,000
- Change %
- Price
-
$0.000000
- Shares after
- 25,000
- Date
- 05 Jan 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,000
- Exercise price
- $3.18
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Explanation of responses
2 footnotes